← back to search

Lin Li

China Pharmaceutical University · CN
Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, and Chromosomal and Genetic Variations.
h-index
33
citations
5,871
works
293
NIH funding
primary concept
email

Recent publications

Enhanced sensitivity in PCSK9 detection using binding-induced DNA walker-triggered Argonaute protein-based DNA circuit
Microchimica Acta 2025cited by 1position: lastdoi
Near-Full-Length Genomic Characterization of Two Novel HIV-1 Unique Recombinants (CRF01_AE/CRF07_BC) and (CRF01_AE/CRF68_01B) in Shijiazhuang, Hebei Province, China
AIDS Research and Human Retroviruses 2025cited by 1position: middledoi
Sequence Notes: Characterization of the Near-Full-Length Genome of Two Novel Unique Recombinant Genome (CRF01_AE/CRF79_0107, CRF01_AE/CRF07_BC) in Hebei, China
AIDS Research and Human Retroviruses 2025cited by 1position: middledoi
Tumor microenvironment activation amplify oxidative stress promoting tumor energy remodeling for mild photothermal therapy and cuproptosis
Redox Biology 2024cited by 24position: middledoi
H2S-driven chemotherapy and mild photothermal therapy induced mitochondrial reprogramming to promote cuproptosis
Journal of Nanobiotechnology 2024cited by 19position: middledoi
IFNAR signaling of neuroectodermal cells is essential for the survival of C57BL/6 mice infected with Theiler’s murine encephalomyelitis virus
Journal of Neuroinflammation 2023cited by 7position: middledoi
T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer
Journal for ImmunoTherapy of Cancer 2022cited by 74position: middledoi
Identification of a new HIV-1 intersubtype circulating recombinant form (CRF123_0107) in Hebei province, China
Journal of Infection 2022cited by 33position: lastdoi
Multiomics analysis of tumor mutational burden across cancer types
Computational and Structural Biotechnology Journal 2021cited by 27position: firstdoi
Identification of Two Novel HIV-1 Second-Generation Recombinant Forms (CRF01_AE/CRF07_BC) in Hebei, China
AIDS Research and Human Retroviruses 2021cited by 17position: middledoi
Maize residue segmentation using Siamese domain transfer network
Computers and Electronics in Agriculture 2021cited by 15position: firstdoi
Rapid prediction of the re-watering time point of Orychophragmus violaceus L. based on the online monitoring of electrophysiological indexes
Scientia Horticulturae 2019cited by 26position: middledoi
Phylodynamics of major CRF01_AE epidemic clusters circulating in mainland of China
Scientific Reports 2017cited by 42position: lastdoi
Diallyl trisulfide induces apoptosis and inhibits proliferation of A549 cells <italic>in vitro</italic> and <italic>in vivo</italic>
Acta Biochimica et Biophysica Sinica 2012cited by 50position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Erhei Dai · Hebei Medical University4 papers (2021–2025)Hanping Li · Southern Medical University4 papers (2021–2025) · 4 papers (2021–2025)Jingyun Li · Tsinghua University2 papers (2021–2022)Kuiling Shen · Hebei Medical University2 papers (2025–2025)Ying Xing · Zhongyuan University of Technology2 papers (2021–2022)Lihong Qiao · Beihang University2 papers (2024–2024)Yuxin Feng · Hebei Medical University2 papers (2025–2025)Chuanqi Wei · Sun Yat-sen University2 papers (2024–2024)Dongsheng Yu · First Affiliated Hospital of Henan University2 papers (2024–2024)Jianmin Yuan · Institute of High Energy Physics2 papers (2024–2024)Yijing Ou · Southern Medical University2 papers (2024–2024)Du Cheng · Animal Husbandry & Veterinary2 papers (2024–2024)Lijing Wang · Guangzhou Medical University2 papers (2021–2022)Yang Li · Nanjing University of Chinese Medicine1 papers (2022–2022)Dandan Li · Nanyang Normal University1 papers (2023–2023)Wenjun Zhang · Northeastern University1 papers (2022–2022)Tianyi Li · Tianjin University of Technology1 papers (2022–2022)Xiaojian Xu · Jiangsu University1 papers (2019–2019)Hui Tian · Johnson & Johnson (United States)1 papers (2012–2012)